NADPH Oxidases (NOX) have been suggested to contribute to the initiation and progression of DKD and other diabetic complications, and their activity is elevated significantly following the onset of hyperglycemia and increased circulating angiotensin II (Ang II), advanced glycation end products (AGEs) and TGFβ1 [66]. The gene discussed is AGT; the disease is Hyperglycemia.